Stock EDAP EDAP TMS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News EDAP TMS S.A.

Equities

EDAP

US2683111072

Delayed Nasdaq
Other stock markets
 10:27:11 2024-04-25 am EDT 		5-day change 1st Jan Change
7.11 USD +3.95% Intraday chart for EDAP TMS S.A. -0.28% +34.66%
Apr. 19 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down MT
Apr. 04 European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
GL
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher
MT
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading
MT
Transcript : EDAP TMS S.A., Q4 2023 Earnings Call, Mar 27, 2024
EDAP TMS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
GL
EDAP TMS S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading
MT
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
GL
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
AQ
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
GL
EDAP TMS S A : Focal One HIFU has potential to address large market impacting thousands of women each year - Form 6-K
PU
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
GL
EDAP TMS SA Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis
CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
MT
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
GL
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EDAP Stock
  4. News EDAP TMS S.A.